Awareness of Fertility Preservation Options may be Low Among Young Cancer Patients

Clinicians must discuss fertility preservation with cancer patients, as it is linked to medical factors, patient socioeconomic status and child-rearing status.

Cancer therapies can cause some patients to become infertile. There is a need to raise awareness of fertility preservation options for young adults with cancer, says a new study.

It important for clinicians and young cancer patients to have discussions about this issue and the available fertility preservation techniques that might be used to overcome it. Little is known about the extent to which these discussions take place, or patient and physician characteristics associated with these interactions.

Naturally Occurring Hormone Induces Egg Maturation During Infertility Treatment
According to a clinical in vitro fertilization (IVF) study, the naturally occurring hormone kisspeptin effectively induces egg maturation during infertility treatment.

The study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treatment.

To investigate, Dr Margarett Shnorhavorian from the University of Washington, Seattle Children’s Hospital, and her colleagues asked 459 adolescents and young adults who were diagnosed with cancer in 2007 or 2008 to complete questionnaires.

More than 70 percent of the patients reported being told that treatment may affect their fertility; however, male patients were more than twice as likely as female patients to report that fertility preservation options were discussed.

Study Reveals Leading Cause Behind 'Unexplained Infertility'
A new research has uncovered the cause of 'unexplained infertility,' providing fresh hope to couples with the condition.

Most striking, almost one-third of males reported making arrangements for fertility preservation, which was four to five times higher than the rate seen in females.

The investigators also found that between 2007 and 2008, males and females both reported an increase in discussions regarding the impact of cancer therapy on fertility and fertility preservation options.

Novel Implant Identifies Suitable Drug for Individualized Cancer Treatment
The implant shows activity of each drug on the tumor and indicates drugs that will work best on the cancer as a whole.

The questionnaires also revealed that discussion and action surrounding fertility preservation may be linked with medical factors, patient socioeconomic status, and child-rearing status.

For example, individuals without insurance, those who were raising children, and, among males only, those who received treatment posing no or low fertility risk were more likely not to discuss fertility preservation with clinicians.

New Approach Accelerates Identification of Cancer Treatments
At the University of Michigan, researchers have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods.

Also, among males, those without a college degree, those who lacked private insurance, and those who were raising children were more likely to not make fertility preservation arrangements; too few females had made fertility preservation arrangements for similar analyses.

“The access and health-related reasons for not making arrangements for fertility preservation reported by participants in this study further highlight the need for decreased cost, improved insurance coverage, and partnerships between cancer healthcare providers and fertility experts to develop strategies that increase awareness of fertility preservation options and decrease delays in cancer therapy as fertility preservation for adolescent and young adult cancer patients improves,” said Dr. Shnorhavorian.

The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Source-Medindia